Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin

Background. People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Shyam Dheda, David A Vesey, Carmel Hawley, David W Johnson, Magid Fahim
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/8632245
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552271612739584
author Shyam Dheda
David A Vesey
Carmel Hawley
David W Johnson
Magid Fahim
author_facet Shyam Dheda
David A Vesey
Carmel Hawley
David W Johnson
Magid Fahim
author_sort Shyam Dheda
collection DOAJ
description Background. People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The origin of this inflammation remains elusive and one putative cause is elevated levels of circulating bacterial endotoxin. Methods. In this study, serum concentrations of endotoxin and inflammatory biomarkers, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), interleukin-1β (IL1β), ferritin and tumor necrosis factor (TNF), were measured in 30 adults receiving HD and 10 healthy individuals without kidney disease. In people receiving HD, samples were collected immediately before dialysis (preHD), after dialysis (postHD), and 48 hours after (postHD48hrs). Results. Endotoxin was detectable in only 1 of 90 samples analyzed. There were no significant differences in serum hsCRP, IL1β, and IL6 levels, before and after dialysis. Serum TNF levels decreased significantly from 30.9 (8.0, 39.5) pg/mL preHD to 13.9 (8.5, 17.3) pg/mL post-HD (p=0.002) and then increased back to 27.37 (14.5, 35) pg/mL 2 days later (p<0.001). Ferritin increased from 1153 ng/mL (782, 1458) preHD to 1313 ng/mL (657, 1638) post HD (p<0.001) and then decreased back to 1186 ng/mL (754, 1597) (p=0.66) postHD48hrs. Compared to controls, people receiving HD had significantly elevated levels of hsCRP [6.16 mg/L (2.1, 16.8) vs. 1.1 mg/L (0.81, 3.63) p=0.015], IL1β [1.5 pg/mL (0.05, 2.51) vs. 0.5 pg/mL (1.81, 2.95) p≤0.001], and ferritin [1153 (782, 1458) vs. 132.9 (111, 257) ng/mL p≤0.001], but comparable levels of in IL6 [6.15 pg/mL (4.82, 9.12) vs. 7.49 pg/mL (4.56, 10.39), p=0.77] and TNF [27.35 pg/mL ± 17.48 vs. 17.87 pg/mL ± 12.28, p<0.12]. In conclusion, people on HD have elevated levels of inflammatory biomarkers, which are not associated with endotoxemia (which is rare) or the dialysis procedure.
format Article
id doaj-art-097ae18fbbad4839b6d3e502f069a19d
institution Kabale University
issn 2042-0099
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Inflammation
spelling doaj-art-097ae18fbbad4839b6d3e502f069a19d2025-02-03T05:59:03ZengWileyInternational Journal of Inflammation2042-00992022-01-01202210.1155/2022/8632245Effect of a Hemodialysis Session on Markers of Inflammation and EndotoxinShyam Dheda0David A Vesey1Carmel Hawley2David W Johnson3Magid Fahim4Centre for Kidney Disease ResearchDepartment of NephrologyCentre for Kidney Disease ResearchCentre for Kidney Disease ResearchCentre for Kidney Disease ResearchBackground. People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The origin of this inflammation remains elusive and one putative cause is elevated levels of circulating bacterial endotoxin. Methods. In this study, serum concentrations of endotoxin and inflammatory biomarkers, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), interleukin-1β (IL1β), ferritin and tumor necrosis factor (TNF), were measured in 30 adults receiving HD and 10 healthy individuals without kidney disease. In people receiving HD, samples were collected immediately before dialysis (preHD), after dialysis (postHD), and 48 hours after (postHD48hrs). Results. Endotoxin was detectable in only 1 of 90 samples analyzed. There were no significant differences in serum hsCRP, IL1β, and IL6 levels, before and after dialysis. Serum TNF levels decreased significantly from 30.9 (8.0, 39.5) pg/mL preHD to 13.9 (8.5, 17.3) pg/mL post-HD (p=0.002) and then increased back to 27.37 (14.5, 35) pg/mL 2 days later (p<0.001). Ferritin increased from 1153 ng/mL (782, 1458) preHD to 1313 ng/mL (657, 1638) post HD (p<0.001) and then decreased back to 1186 ng/mL (754, 1597) (p=0.66) postHD48hrs. Compared to controls, people receiving HD had significantly elevated levels of hsCRP [6.16 mg/L (2.1, 16.8) vs. 1.1 mg/L (0.81, 3.63) p=0.015], IL1β [1.5 pg/mL (0.05, 2.51) vs. 0.5 pg/mL (1.81, 2.95) p≤0.001], and ferritin [1153 (782, 1458) vs. 132.9 (111, 257) ng/mL p≤0.001], but comparable levels of in IL6 [6.15 pg/mL (4.82, 9.12) vs. 7.49 pg/mL (4.56, 10.39), p=0.77] and TNF [27.35 pg/mL ± 17.48 vs. 17.87 pg/mL ± 12.28, p<0.12]. In conclusion, people on HD have elevated levels of inflammatory biomarkers, which are not associated with endotoxemia (which is rare) or the dialysis procedure.http://dx.doi.org/10.1155/2022/8632245
spellingShingle Shyam Dheda
David A Vesey
Carmel Hawley
David W Johnson
Magid Fahim
Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
International Journal of Inflammation
title Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_full Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_fullStr Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_full_unstemmed Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_short Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_sort effect of a hemodialysis session on markers of inflammation and endotoxin
url http://dx.doi.org/10.1155/2022/8632245
work_keys_str_mv AT shyamdheda effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT davidavesey effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT carmelhawley effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT davidwjohnson effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT magidfahim effectofahemodialysissessiononmarkersofinflammationandendotoxin